Role of interleukin-10 in breast cancer

Breast Cancer Research and Treatment

Volumn 133, Issue 1, 2012, Pages 11-21

  Hamidullah, ^a   Changkija, Bendangla ^a   Konwar, Rituraj ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

Breast cancer; Cytokine; IL 10

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; AMMONIUM TRICHLORO(DIOXYETHYLENE O,O')TELLURATE; CYCLOSPORIN; ESTROGEN RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 6; PACLITAXEL; PROTEIN BCL 2; RITUXIMAB; STAT3 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 3;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; BREAST ADENOCARCINOMA; BREAST CANCER; BREAST CARCINOGENESIS; BREAST TUMOR; CANCER GROWTH; CANCER INHIBITION; CANCER STAGING; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HUMAN; INTERLEUKIN 10 GENE; MACROPHAGE; MAST CELL; METASTASIS INHIBITION; MONOCYTE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; REVIEW; TH17 CELL; TUMOR REGRESSION; TUMOR VASCULARIZATION;

ANIMALS; BREAST NEOPLASMS; CYTOKINES; FEMALE; HUMANS; IMMUNE SYSTEM; INTERLEUKIN-10; POLYMORPHISM, GENETIC; PROGNOSIS; SIGNAL TRANSDUCTION; TUMOR MARKERS, BIOLOGICAL;

EID: 84860341228     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-011-1855-x     Document Type: Review

References (120)

1. DM Parkin F Bray J Ferlay P Pisani 2005 Global cancer statistics, 2002 CA Cancer J Clin 55 74 108 15761078 10.3322/canjclin.55.2.74 (Pubitemid 40372904)
2. DM Parkin LM Fernandez 2006 Use of statistics to assess the global burden of breast cancer Breast J 12 Suppl. 1 70 80 10.1111/j.1075-122X.2006.00205.x (Pubitemid 43385274)
3. MJ Smyth E Cretney MH Kershaw Y Hayakawa 2004 Cytokines in cancer immunity and immunotherapy Immunol Rev 202 275 293 15546400 1:CAS:528: DC%2BD2MXhs1Ogsg%3D%3D 10.1111/j.0105-2896.2004.00199.x (Pubitemid 39576919)
4. LJ Standish ES Sweet J Novack CA Wenner C Bridge A Nelson M Martzen C Torkelson 2008 Breast cancer and the immune system J Soc Integr Oncol 6 4 158 168 19134448
5. DG DeNardo LM Coussens 2007 Inflammation and breast cancer. Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression Breast Cancer Res 9 4 212 17705880 10.1186/bcr1746 1:CAS:528:DC%2BD2sXhtVOntLjJ
6. VS Rao CE Dyer JK Jameel PJ Drew J Greenman 2006 Potential prognostic and therapeutic roles for cytokines in breast cancer (Review) Oncol Rep 15 1 179 185 16328053 1:CAS:528:DC%2BD2sXhsVGru7bK
7. A Carpi A Nicolini A Antonelli P Ferrari G Rossi 2009 Cytokines in the management of high risk or advanced breast cancer: an update and expectation Curr Cancer Drug Target 9 8 888 903 1:CAS:528:DC%2BC3cXhslKnsL0%3D 10.2174/156800909790192392
8. R Konwar P Chaudhary S Kumar D Mishra N Chattopadhyay HK Bid 2009 Breast cancer risk associated with polymorphisms of IL-1RN and IL-4 gene in Indian women Oncol Res 17 8 367 372 19544973 10.3727/096504009788428442
9. KW Moore A O'Garra MR de Waal P Vieira TR Mosmann 1993 Interleukin-10 Annu Rev Immunol 11 165 190 8386517 1:CAS:528:DyaK3sXktVKmu7o%3D 10.1146/annurev.iy.11.040193.001121 (Pubitemid 23115005)
10. Fitzgerald KA, O'Neill LAJ, Gearing AJH, Callard RE (2001) The cytokine facts book, 2nd edn. Academic Press, London
11. AB Lentsch TP Shanley V Sarma PA Ward 1997 In vivo suppression of NF-kappa B and preservation of I kappa B alpha by interleukin-10 and interleukin-13 J Clin Invest 100 10 2443 2448 9366558 1:CAS:528: DyaK2sXnsVymtL8%3D 10.1172/JCI119786 (Pubitemid 27514883)
12. SV Kotenko CD Krause LS Izotova BP Pollack W Wu S Pestka 1997 Identification and functional characterization of a second chain of the interleukin-10 receptor complex EMBO J 16 19 5894 5903 9312047 1:CAS:528:DyaK2sXntVKgsL8%3D 10.1093/emboj/16.19.5894 (Pubitemid 27427285)
13. TR Mosmann 1994 Properties and functions of interleukin-10 Adv Immunol 56 1 26 8073945 1:CAS:528:DyaK2cXmt1yjtbk%3D 10.1016/S0065-2776(08)60449-6 (Pubitemid 24242221)
14. M Howard A O'Garra 1992 Biological properties of interleukin 10 Immunol Today 13 6 198 200 1385707 1:CAS:528:DyaK38XlsVyls7c%3D 10.1016/0167-5699(92) 90153-X
15. KW Moore R de Waal Malefyt RL Coffman A O'Garra 2001 Interleukin-10 and the interleukin-10 receptor Annu Rev Immunol 19 683 765 11244051 1:CAS:528:DC%2BD3MXivFKgu70%3D 10.1146/annurev.immunol.19.1.683 (Pubitemid 32368050)
16. S Pestka CD Krause D Sarkar MR Walter Y Shi PB Fisher 2004 Interleukin-10 and related cytokines and receptors Annu Rev Immunol 22 929 979 15032600 1:CAS:528:DC%2BD2cXktlOgsbg%3D 10.1146/annurev.immunol.22.012703.104622 (Pubitemid 38680445)
17. W Ouyang S Rutz NK Crellin PA Valdez SG Hymowitz 2011 Regulation and functions of the IL-10 family of cytokines in inflammation and disease Annu Rev Immunol 29 71 109 21166540 1:CAS:528:DC%2BC3MXltlKnsrc%3D 10.1146/annurev- immunol-031210-101312
18. R de Waal Malefyt H Yssel MG Roncarolo H Spits JE de Vries 1992 Interleukin-10 Curr Opin Immunol 4 3 314 320 1418711 10.1016/0952-7915(92)90082- P
19. K Asadullah W Sterry HD Volk 2003 Interleukin-10 therapy-review of a new approach Pharmacol Rev 55 2 241 269 12773629 1:CAS:528:DC%2BD3sXltVSgtbk%3D 10.1124/pr.55.2.4 (Pubitemid 36666048)
20. R Sabat G Grütz K Warszawska S Kirsch E Witte K Wolk J Geginat 2010 Biology of interleukin-10 Cytokine Growth Factor Rev 21 5 331 344 21115385 1:CAS:528:DC%2BC3cXhsFamt7zJ 10.1016/j.cytogfr.2010.09.002
21. K Wolk S Kunz K Asadullah R Sabat 2002 Cutting edge: immune cells as sources and targets of the IL-10 family members? J Immunol 168 11 5397 5402 12023331 1:CAS:528:DC%2BD38XktFCrsro%3D (Pubitemid 34556115)
22. KN Couper DG Blount EM Riley 2008 IL-10: the master regulator of immunity to infection J Immunol 180 9 5771 5777 18424693 1:CAS:528:DC%2BD1cXkvVequ7o%3D
23. A O'Garra P Vieira 2007 TH1 cells control themselves by producing interleukin-10 Nat Rev Immunol 7 425 428 17525751 10.1038/nri2097 1:CAS:528:DC%2BD2sXls1Kgt70%3D (Pubitemid 46834852)
24. AS Ho SH Wei AL Mui A Miyajima KW Moore 1995 Functional regions of the mouse interleukin-10 receptor cytoplasmic domain Mol Cell Biol 15 5043 5053 7544437 1:CAS:528:DyaK2MXns1amur8%3D
25. DS Finbloom KD Winestock 1995 IL-10 induces the tyrosine phosphorylation of tyk2 and Jak1 and the differential assembly of STAT1 alpha and STAT3 complexes in human T cells and monocytes J Immunol 155 3 1079 1090 7543512 1:CAS:528:DyaK2MXntFWntbY%3D
26. CF Lai J Ripperger KK Morella J Jurlander TS Hawley WE Carson T Kordula MA Caligiuri RG Hawley GH Fey H Baumann 1996 Receptors for interleukin (IL)-10 and IL-6-type cytokines use similar signaling mechanisms for inducing transcription through IL-6 response elements J Biol Chem 271 24 13968 13975 8662928 1:CAS:528:DyaK28Xjs1OisLg%3D 10.1074/jbc.271.24.13968 (Pubitemid 26190286)
27. LM Williams G Ricchetti U Sarma T Smallie BM Foxwell 2004 Interleukin-10 suppression of myeloid cell activation-a continuing puzzle Immunology 113 3 281 292 15500614 1:CAS:528:DC%2BD2cXpvV2jtbY%3D 10.1111/j.1365-2567.2004.01988.x (Pubitemid 39472144)
28. A Braunschweig TG Poehlmann S Busch E Schleussner UR Markert 2011 Signal transducer and activator of transcription 3 (STAT3) and suppressor of cytokine signaling (SOCS3) balance controls cytotoxicity and IL-10 expression in decidual-like natural killer cell line NK-92 Am J Reprod Immunol 66 3 329 335 21385272 1:CAS:528:DC%2BC3MXhtlCnsLfP 10.1111/j.1600-0897.2011.00989.x
29. EB Lee A Kim K Kang H Kim JS Lim 2010 NDRG2-mediated modulation of SOCS3 and STAT3 activity inhibits IL-10 production Immune Netw 10 6 219 229 21286383 10.4110/in.2010.10.6.219
30. JJ Haddad NE Saadé B Safieh-Garabedian 2003 Interleukin-10 and the regulation of mitogen-activated protein kinases: are these signalling modules targets for the anti-inflammatory action of this cytokine? Cell Signal 15 3 255 267 12531424 1:CAS:528:DC%2BD3sXivVKhtA%3D%3D 10.1016/S0898-6568(02)00075-X (Pubitemid 36071670)
31. S Kruger-Krasagakes K Krasagakis C Garbe E Schmitt C Hüls T Blankenstein T Diamantstein 1994 Expression of interleukin 10 in human melanoma Br J Cancer 70 6 1182 1185 7981073 1:STN:280:DyaK2M%2FntFyltw%3D%3D 10.1038/bjc.1994.469 (Pubitemid 24358959)
32. GA Gastl JS Abrams DM Nanus R Oosterkamp J Silver F Liu M Chen AP Albino NH Bander 1993 Interleukin-10 production by human carcinoma cell lines and its relationship to interleukin-6 expression Int J Cancer 55 1 96 101 8344757 1:CAS:528:DyaK2cXhs1Shsbc%3D 10.1002/ijc.2910550118 (Pubitemid 23261713)
33. U Joimel C Gest J Soria LL Pritchard J Alexandre M Laurent E Blot L Cazin JP Vannier R Varin, et al. 2010 Stimulation of angiogenesis resulting from cooperation between macrophages and MDA-MB-231 breast cancer cells: proposed molecular mechanism and effect of tetrathiomolybdate BMC Cancer 10 375 20637124 10.1186/1471-2407-10-375 1:CAS:528:DC%2BC3cXptF2hsrg%3D
34. E Venetsanakos I Beckman J Bradley JM Skinner 1997 High incidence of interleukin 10 mRNA but not interleukin 2 mRNA detected in human breast tumours Br J Cancer 75 12 1826 1830 9192989 1:CAS:528:DyaK2sXksVWqsbs%3D 10.1038/bjc.1997.311 (Pubitemid 27230711)
35. Al-Sarireh B, Sathaporn S, Robins A, Jenkin D, Vassanasiri W, El-Sheemy M, Jibril JA, Clark D, Eremin O (2010) Mononuclear phagocytes but not tumour cells are the main source of elevated inter-leukin (IL)-10 levels in human breast cancer. Surgeons in training 2000. The Royal College of Surgeons of Edinburgh. Retrieved on 02 December 2010 from http://www.rcsed.ac.uk/Journal/ vol46-1/4610011.htm
36. C Bogdan Y Vodovotz C Nathan 1991 Macrophage deactivation by interleukin 10 J Exp Med 174 6 1549 1555 1744584 1:CAS:528:DyaK3MXmtlSiu78%3D 10.1084/jem.174.6.1549
37. SI Hashimoto I Komuro M Yamada KS Akagawa 2001 IL-10 inhibits granulocyte-macrophage colony-stimulating factor-dependent human monocyte survival at the early stage of the culture and inhibits the generation of macrophages J Immunol 167 7 3619 3625 11564774 1:CAS:528:DC%2BD3MXntFajsLo%3D (Pubitemid 32910803)
38. DL Commeren PL Van Soest K Karimi B Löwenberg JJ Cornelissen E Braakman 2003 Paradoxical effects of interleukin-10 on the maturation of murine myeloid dendritic cells Immunology 110 2 188 196 14511232 1:CAS:528: DC%2BD3sXotFSmur4%3D 10.1046/j.1365-2567.2003.01730.x (Pubitemid 37249258)
39. R de Waal Malefyt J Haanen H Spits MG Roncarolo A te Velde C Figdor K Johnson R Kastelein H Yssel JE de Vries 1991 Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression J Exp Med 174 4 915 924 1655948 10.1084/jem.174.4.915
40. DF Fiorentino A Zlotnik P Vieira TR Mosmann M Howard KW Moore A O'Garra 1991 IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells J Immunol 146 10 3444 3451 1827484 1:CAS:528:DyaK3MXltleksLg%3D
41. SE Macatonia TM Doherty SC Knight A O'Garra 1993 Differential effect of IL-10 on dendritic cell-induced T cell proliferation and IFN-gamma production J Immunol 150 9 3755 3765 8097224 1:CAS:528:DyaK3sXkt1Kns7Y%3D (Pubitemid 23129757)
42. R de Waal Malefyt J Abrams B Bennett CG Figdor JE de Vries 1991 Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes J Exp Med 174 5 1209 1220 1940799 10.1084/jem.174.5.1209
43. DF Fiorentino A Zlotnik TR Mosmann M Howard A O'Garra 1991 IL-10 inhibits cytokine production by activated macrophages J Immunol 147 11 3815 3822 1940369 1:CAS:528:DyaK38XlslSgug%3D%3D
44. JK Jenkins M Malyak WP Arend 1994 The effects of interleukin-10 on interleukin-1 receptor antagonist and interleukin-1 beta production in human monocytes and neutrophils Lymphokine Cytokine Res 13 1 47 54 8186324 1:CAS:528:DyaK2cXisVaitLg%3D (Pubitemid 24080654)
45. + T cells in an interleukin-10-dependent manner Immunity 34 4 554 565 21511184 1:CAS:528:DC%2BC3MXltVGmsb4%3D 10.1016/j.immuni.2011.01.020
46. A Chaudhry RM Samstein P Treuting Y Liang MC Pils JM Heinrich RS Jack FT Wunderlich JC Brüning W Müller, et al. 2011 Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation Immunity 34 4 566 578 21511185 1:CAS:528:DC%2BC3MXltVGmsb8%3D 10.1016/j.immuni.2011.03.018
47. DE Scott WC Gause FD Finkelman AD Steinberg 1990 Anti-CD3 antibody induces rapid expression of cytokine genes in vivo J Immunol 145 7 2183 2188 2144547 1:CAS:528:DyaK3cXmtV2mtbY%3D (Pubitemid 20343383)
48. C Pilette KT Nouri-Aria MR Jacobson LK Wilcock B Detry SM Walker JN Francis SR Durham 2007 Grass pollen immunotherapy induces an allergen-specific IgA2 antibody response associated with mucosal TGF-beta expression J Immunol 178 7 4658 4666 17372025 1:CAS:528:DC%2BD2sXjt1WksLc%3D (Pubitemid 46492419)
49. F Geissmann P Launay B Pasquier Y Lepelletier M Leborgne A Lehuen N Brousse RC Monteiro 2001 A subset of human dendritic cells expresses IgA Fc receptor (CD89), which mediates internalization and activation upon cross-linking by IgA complexes J Immunol 166 1 346 352 11123311 1:CAS:528:DC%2BD3MXis1eiug%3D%3D (Pubitemid 32038451)
50. MJ McGeachy KS Bak-Jensen Y Chen CM Tato W Blumenschein T McClanahan DJ Cua 2007 TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology Nat Immunol 8 12 1390 1397 17994024 1:CAS:528:DC%2BD2sXhtlajtr7K 10.1038/ni1539 (Pubitemid 350138974)
51. A Awasthi Y Carrier JP Peron E Bettelli M Kamanaka RA Flavell VK Kuchroo M Oukka HL Weiner 2007 A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells Nat Immunol 8 12 1380 1389 17994022 1:CAS:528:DC%2BD2sXhtlajtr7I 10.1038/ni1541 (Pubitemid 350131175)
52. DC Fitzgerald GX Zhang M El-Behi Z Fonseca-Kelly H Li S Yu CJ Saris B Gran B Ciric A Rostami 2007 Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells Nat Immunol 8 12 1372 1379 17994023 1:CAS:528:DC%2BD2sXhtlajtr7L 10.1038/ni1540 (Pubitemid 350131174)
53. G Pang L Couch R Batey R Clancy A Cripps 1994 GM-CSF, IL-1 alpha, IL-1 beta, IL-6, IL-8, IL-10, ICAM-1 and VCAM-1 gene expression and cytokine production in human duodenal fibroblasts stimulated with lipopolysaccharide, IL-1 alpha and TNF-alpha Clin Exp Immunol 96 3 437 443 8004813 1:CAS:528:DyaK2cXltVKgsrs%3D 10.1111/j.1365-2249.1994.tb06048.x
54. Kim KH, Kim DI, Kim SH, Jung EM, Kang JH, Jeung EB, Yang MP (2011) Trans-10, cis-12-conjugated linoleic acid attenuates tumor necrosis factor-α production by lipopolysaccharide-stimulated porcine peripheral blood mononuclear cells through induction of interleukin-10. Cytokine; doi: 10.1016/j.cyto.2011.06.019
55. RL Brunsing ER Prossnitz 2011 Induction of interleukin-10 in the T helper type 17 effector population by the G protein coupled estrogen receptor (GPER) agonist G-1 Immunology 134 1 93 106 21722102 1:CAS:528:DC%2BC3MXhtVOqtbrK 10.1111/j.1365-2567.2011.03471.x
56. M Lazarini F Traina SM Winnischofer FF Costa ML Queiroz ST Saad 2011 Effects of thalidomide on long-term bone marrow cultures from patients with myelodysplastic syndromes: induction of IL-10 expression in the stromal layers Leuk Res 35 8 1102 1107 21511336 1:CAS:528:DC%2BC3MXptVymt7g%3D 10.1016/j.leukres.2011.03.027
57. Lian ZR, Xu YF, Wang XB, Gong JP, Liu ZJ (2011) Suppression of Histone Deacetylase 11 Promotes Expression of IL-10 in Kupffer Cells and Induces Tolerance Following Orthotopic Liver Transplantation in Rats. J Surg Res; doi: 10.1016/j.jss.2010.12.035
58. Municio C, Hugo E, Alvarez Y, Alonso S, Blanco L, Fernández N, Sánchez Crespo M (2011) Apoptotic cells enhance IL-10 and reduce IL-23 production in human dendritic cells treated with zymosan. Mol Immunol; doi: 10.1016/j.molimm.2011.07.022
59. J Xu Y Yang G Qiu G Lal Z Wu DE Levy JC Ochando JS Bromberg Y Ding 2009 c-Maf regulates IL-10 expression during Th17 polarization J Immunol 182 10 6226 6236 19414776 1:CAS:528:DC%2BD1MXltlyntbY%3D 10.4049/jimmunol.0900123
60. P Durez D Abramowicz C Gérard M Van Mechelen Z Amraoui C Dubois O Leo T Velu M Goldman 1993 In vivo induction of interleukin 10 by anti-CD3 monoclonal antibody or bacterial lipopolysaccharide: differential modulation by cyclosporin A J Exp Med 177 2 551 555 8426125 1:CAS:528:DyaK3sXnvFWhsg%3D%3D 10.1084/jem.177.2.551 (Pubitemid 23117108)
61. JD Ji HJ Kim YH Rho SJ Choi YH Lee HJ Cheon J Sohn GG Song 2005 Inhibition of IL-10-induced STAT3 activation by 15-deoxy-Delta12, 14-prostaglandin J2 Rheumatology (Oxford) 44 8 983 988 1:CAS:528: DC%2BD2MXmsV2is70%3D 10.1093/rheumatology/keh657 (Pubitemid 41487169)
62. Y Kalechman U Gafter T Weinstein A Chagnac I Freidkin A Tobar M Albeck B Sredni 2004 Inhibition of interleukin-10 by the immunomodulator AS101 reduces mesangial cell proliferation in experimental mesangioproliferative glomerulonephritis: association with dephosphorylation of STAT3 J Biol Chem 279 23 24724 24732 15001575 1:CAS:528:DC%2BD2cXksV2iu74%3D 10.1074/jbc.M312006200 (Pubitemid 38725340)
63. S Alas C Emmanouilides B Bonavida 2001 Inhibition of interleukin 10 by rituximab results in down-regulation of bcl-2 and sensitization of B-cell non-Hodgkin's lymphoma to apoptosis Clin Cancer Res 7 3 709 723 11297268 1:CAS:528:DC%2BD3MXjtVOnsr0%3D (Pubitemid 32707998)
64. N Kundu TL Beaty MJ Jackson AM Fulton 1996 Antimetastatic and antitumor activities of interleukin 10 in a murine model of breast cancer J Natl Cancer Inst 88 8 536 541 8606382 1:CAS:528:DyaK28XislKju70%3D 10.1093/jnci/88.8.536 (Pubitemid 26118724)
65. S Mocellin FM Marincola HA Young 2005 Interleukin-10 and the immune response against cancer: a counterpoint J Leukoc Biol 78 5 1043 1051 16204623 1:CAS:528:DC%2BD2MXht1ShsL%2FN 10.1189/jlb.0705358 (Pubitemid 41572467)
66. A Pinzon-Charry T Maxwell JA López 2005 Dendritic cell dysfunction in cancer: a mechanism for immunosuppression Immunol Cell Biol 83 5 451 461 16174093 1:CAS:528:DC%2BD2MXhtFeqtrnI 10.1111/j.1440-1711.2005.01371.x (Pubitemid 41805745)
67. D Hanahan RA Weinberg 2011 Hallmarks of cancer: the next generation Cell 144 5 646 674 21376230 1:CAS:528:DC%2BC3MXjsFeqtrk%3D 10.1016/j.cell.2011.02.013
68. SB Cohen JB Crawley MC Kahan M Feldmann BM Foxwell 1997 Interleukin-10 rescues T cells from apoptotic cell death: association with an upregulation of Bcl-2 Immunology 92 1 5 9370916 1:CAS:528:DyaK2sXlvVyltL4%3D 10.1046/j.1365-2567.1997.00348.x (Pubitemid 27380873)
69. K Taga B Cherney G Tosato 1993 IL-10 inhibits apoptotic cell death in human T cells starved of IL-2 Int Immunol 5 1599 1608 8312229 1:CAS:528:DyaK2cXnsFajtw%3D%3D 10.1093/intimm/5.12.1599 (Pubitemid 24008920)
70. S Alas B Bonavida 2001 Rituximab inactivates signal transducer and activation of transcription 3 (stat3) activity in b-nonhodgkin's lymphoma through inhibition of the interleukin 10 autocrine/paracrine loop and results in down-regulation of bcl-2 and sensitization to cytotoxic drugs Cancer Res 61 5137 5144 11431352 1:CAS:528:DC%2BD3MXltVequ7c%3D (Pubitemid 32681546)
71. XZ Wang SJ Zhang YX Chen ZX Chen YH Huang LJ Zhang 2004 Effects of platelet-derived growth factor and interleukin-10 on Fas/Fas-ligand and Bcl-2/Bax mRNA expression in rat hepatic stellate cells in vitro World J Gastroenterol 10 2706 2710 15309723 1:CAS:528:DC%2BD2cXnvFWqsr8%3D
72. L Zeng C O'Connor J Zhang AM Kaplan DA Cohen 2010 IL-10 promotes resistance to apoptosis and metastatic potential in lung tumor cell lines Cytokine 49 3 294 302 20034810 1:CAS:528:DC%2BC3cXhslWqtbk%3D 10.1016/j.cyto.2009.11.015
73. JG Fox BJ Sheppard CA Dangler MT Whary M Ihrig TC Wang 2002 Germ-line p53-targeted disruption inhibits helicobacter induced premalignant lesions and invasive gastric carcinoma through down-regulation of Th1 proinflammatory responses Cancer Res 62 696 702 11830522 1:CAS:528:DC%2BD38Xht1KrtbY%3D (Pubitemid 34126943)
74. Y Okuda M Okuda CC Bernard 2003 Regulatory role of p53 in experimental autoimmune encephalomyelitis J Neuroimmunol 135 29 37 12576221 1:CAS:528:DC%2BD3sXovFCitQ%3D%3D 10.1016/S0165-5728(02)00428-9 (Pubitemid 36170148)
75. K Ohkuso-Tsukada T Tsukada KI Isobe 1999 Accelerated development and aging of the immune system in p53-deficient mice J Immunol 163 1966 1972 (Pubitemid 29382199)
76. T Kohno H Mizukami M Suzuki Y Saga Y Takei M Shimpo T Matsushita T Okada Y Hanazono A Kume I Sato K Ozawa 2003 Interleukin-10-mediated inhibition of angiogenesis and tumor growth in mice bearing VEGF-producing ovarian cancer Cancer Res 63 16 5091 5094 12941839 1:CAS:528:DC%2BD3sXms12nsbc%3D (Pubitemid 37022649)
77. ME Stearns J Rhim M Wang 1999 Interleukin 10 (IL-10) inhibition of primary human prostate cell-induced angiogenesis: IL-10 stimulation of tissue inhibitor of metalloproteinase-1 and inhibition of matrix metalloproteinase (MMP)-2/MMP-9 secretion Clin Cancer Res 5 1 189 196 9918218 1:CAS:528: DyaK1MXhtVShtbg%3D (Pubitemid 29045193)
78. ML García-Hernández R Hernández-Pando P Gariglio J Berumen 2002 Interleukin-10 promotes B16-melanoma growth by inhibition of macrophage functions and induction of tumour and vascular cell proliferation Immunology 105 2 231 243 11872099 10.1046/j.1365-2567.2002.01363.x (Pubitemid 34146690)
79. S Huang K Xie CD Bucana SE Ullrich M Bar-Eli 1996 Interleukin 10 suppresses tumor growth and metastasis of human melanoma cells: potential inhibition of angiogenesis Clin Cancer Res 2 12 1969 1979 9816156 1:CAS:528:DyaK2sXitlKrug%3D%3D (Pubitemid 27006629)
80. S Fujii K Shimizu T Shimizu MT Lotze 2001 Interleukin-10 promotes the maintenance of antitumor CD8(+) T-cell effector function in situ Blood 98 7 2143 2151 11568001 1:CAS:528:DC%2BD3MXnsVChtr0%3D 10.1182/blood.V98.7.2143
81. + T cells mediate tumor rejection J Immunol 168 1 1 4 11751938 1:CAS:528:DC%2BD38Xht1Cqtw%3D%3D (Pubitemid 34014094)
82. A Garcia-Lora I Algarra F Garrido 2003 MHC class I antigens, immune surveillance, and tumor immune escape J Cell Physiol 195 3 346 355 12704644 1:CAS:528:DC%2BD3sXjs1yhs7w%3D 10.1002/jcp.10290 (Pubitemid 36529863)
83. E Di Carlo A Coletti A Modesti M Giovarelli G Forni P Musiani 1998 Local release of interleukin-10 by transfected mouse adenocarcinoma cells exhibits pro- and anti-inflammatory activity and results in a delayed tumor rejection Eur Cytokine Netw 9 1 61 68 9613679 1:CAS:528:DyaK1cXjsFKjsrs%3D (Pubitemid 28230185)
84. HL Kaufman JB Rao KR Irvine V Bronte SA Rosenberg NP Restifo 1999 Interleukin-10 enhances the therapeutic effectiveness of a recombinant poxvirus-based vaccine in an experimental murine tumor model J Immunother 22 6 489 496 10570747 1:CAS:528:DyaK1MXnvVKgu7k%3D 10.1097/00002371-199911000-00003 (Pubitemid 29526344)
85. R Dorsey N Kundu Q Yang CS Tannenbaum H Sun TA Hamilton AM Fulton 2002 Immunotherapy with interleukin-10 depends on the CXC chemokines inducible protein-10 and monokine induced by IFN-gamma Cancer Res 62 9 2606 2610 11980656 1:CAS:528:DC%2BD38XjtlGrtrg%3D (Pubitemid 34462741)
86. A Allione M Consalvo P Nanni PL Lollini F Cavallo M Giovarelli M Forni A Gulino MP Colombo P Dellabona, et al. 1994 Immunizing and curative potential of replicating and nonreplicating murine mammary adenocarcinoma cells engineered with interleukin (IL)-2, IL-4, IL-6, IL-7, IL-10, tumor necrosis factor alpha, granulocyte-macrophage colony-stimulating factor, and gamma-interferon gene or admixed with conventional adjuvants Cancer Res 54 23 6022 6026 7954438 1:CAS:528:DyaK2MXisVSqsL8%3D
87. M Giovarelli P Musiani A Modesti P Dellabona G Casorati A Allione M Consalvo F Cavallo F di Pierro C De Giovanni 1995 Local release of IL-10 by transfected mouse mammary adenocarcinoma cells does not suppress but enhances antitumor reaction and elicits a strong cytotoxic lymphocyte and antibody-dependent immune memory J Immunol 155 6 3112 3123 7673726 1:CAS:528:DyaK2MXnvFCitLo%3D
88. N Kundu R Dorsey MJ Jackson P Guiterrez K Wilson S Fu K Ramanujam E Thomas AM Fulton 1998 Interleukin-10 gene transfer inhibits murine mammary tumors and elevates nitric oxide Int J Cancer 76 5 713 719 9610731 1:CAS:528:DyaK1cXjsFeku7o%3D 10.1002/(SICI)1097-0215(19980529)76:5<713::AID- IJC17>3.0.CO;2-4 (Pubitemid 28243946)
89. S Paul A Biswas K Sasmal S Mukherjee T Biswas R Biswas 2010 IL-10 alters prolactin receptor activity emulating that during breast cancer Cytokine 51 2 144 150 20488724 1:CAS:528:DC%2BC3cXosV2jtrw%3D 10.1016/j.cyto.2010.04.012
90. BK Halak HC Maguire Jr EC Lattime 1999 Tumor-induced interleukin-10 inhibits type 1 immune responses directed at a tumor antigen as well as a non-tumor antigen present at the tumor site Cancer Res 59 4 911 917 10029084 1:CAS:528:DyaK1MXht1Sgt7w%3D (Pubitemid 29086748)
91. Abbas AK, Lichtman AH (2006) Cellular and molecular immunology, 5th edn. Elsevier, Amsterdam
92. H Knüpfer R Preiss 2007 Significance of interleukin-6 (IL-6) in breast cancer (review) Breast Cancer Res Treat 102 129 135 16927176 10.1007/s10549-006-9328-3 1:CAS:528:DC%2BD2sXjt1Kquro%3D (Pubitemid 46452175)
93. PC Heinrich I Behrmann G Muller-Newen F Schaper L Graeve 1998 Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway Biochem J 334 Pt 2 297 314 9716487 1:CAS:528:DyaK1cXmtFOls7c%3D (Pubitemid 28448572)
94. E Kovacs 2001 Investigation of interleukin-6 (IL-6), soluble IL-6 receptor (sIL-6R) and soluble gp130 (sgp130) in sera of cancer patients Biomed Pharmacother 55 7 391 396 11669502 1:CAS:528:DC%2BD3MXptVCqsrc%3D 10.1016/S0753-3322(01)00079-8 (Pubitemid 32900539)
95. L Kozłowski I Zakrzewska P Tokajuk MZ Wojtukiewicz 2003 Concentration of interleukin-6 (IL-6), interleukin-8 (IL-8) and interleukin-10 (IL-10) in blood serum of breast cancer patients Rocz Akad Med Bialymst 48 82 84 14737948
96. C Chavey F Bibeau S Gourgou-Bourgade S Burlinchon F Boissière D Laune S Roques G Lazennec 2007 Oestrogen receptor negative breast cancers exhibit high cytokine content Breast Cancer Res 9 1 R15 17261184 10.1186/bcr1648 1:CAS:528:DC%2BD2sXhs1ansr0%3D (Pubitemid 350215146)
97. DE Lyon NL McCain J Walter 2008 Cytokine comparison between women with breast cancer and women with a negative breast biopsy Nurs Res 57 1 51 58 18091292 10.1097/01.NNR.0000280655.58266.6c
98. H Akbulut Y Tang KG Akbulut J Maynard A Deisseroth 2008 Chemotherapy targeted to cancer tissue potentiates antigen-specific immune response induced by vaccine for in vivo antigen loading and activation of dendritic cells Mol Ther 16 10 1753 1760 18728641 1:CAS:528:DC%2BD1cXhtFGhs7jE 10.1038/mt.2008.158
99. L Pusztai TR Mendoza JM Reuben MM Martinez JS Willey J Lara A Syed HA Fritsche E Bruera D Booser, et al. 2004 Changes in plasma levels of inflammatory cytokines in response to paclitaxel chemotherapy Cytokine 25 3 94 102 14698135 1:CAS:528:DC%2BD3sXhtVSju7jL 10.1016/j.cyto.2003.10.004 (Pubitemid 38096266)
100. M Lee SS Yea YJ Jeon 2000 Paclitaxel causes mouse splenic lymphocytes to a state hyporesponsive to lipopolysaccharide stimulation Int J Immunopharmacol 22 8 615 621 10988356 1:CAS:528:DC%2BD3cXlvVCitrs%3D 10.1016/S0192-0561(00) 00024-2 (Pubitemid 30320801)
101. BM Nolen JR Marks S Ta'san A Rand TM Luong Y Wang K Blackwell AE Lokshin 2008 Serum biomarker profiles and response to neoadjuvant chemotherapy for locally advanced breast cancer Breast Cancer Res 10 3 R45 18474099 10.1186/bcr2096 1:CAS:528:DC%2BD1cXms1artLg%3D
102. L Llanes-Fernandez RI Alvarez-Goyanes C Arango-Prado Mdel JM Alcocer-Gonzalez JC Mojarrieta XE Perez MO Lopez SF Odio R Camacho- Rodríguez ME Guerra-Yi, et al. 2006 Relationship between IL-10 and tumor markers in breast cancer patients Breast 15 4 482 489 16403632 10.1016/j.breast.2005.09.012 (Pubitemid 44159219)
103. RA Merendino A Arena AB Capozza S Chillemi M Mesiti 1996 Serum levels of interleukin-10 in patients affected by breast cancer Immunol Lett 53 1 59 60 8946219 1:CAS:528:DyaK28XmsVylt78%3D 10.1016/0165-2478(96)02598-9 (Pubitemid 26376027)
104. RA Merendino S Gangemi A Misefari A Arena AB Capozza S Chillemi FP D'Ambrosio 1999 Interleukin-12 and interleukin-10 production by mononuclear phagocytic cells from breast cancer patients Immunol Lett 68 2-3 355 358 10424443 1:CAS:528:DyaK1MXksFeis7c%3D 10.1016/S0165-2478(99)00067-X (Pubitemid 29301899)
105. KS Son HS Kang SJ Kim SY Jung SY Min SY Lee SW Kim Y Kwon KS Lee KH Shin, et al. 2010 Hypomethylation of the interleukin-10 gene in breast cancer tissues Breast 19 6 484 488 20646924 10.1016/j.breast.2010.05.011
106. M Razmkhah M Jaberipour N Erfani M Habibagahi AR Talei A Ghaderi 2011 Adipose derived stem cells (ASCs) isolated from breast cancer tissue express IL-4, IL-10 and TGF-β1 and upregulate expression of regulatory molecules on T cells: do they protect breast cancer cells from the immune response? Cell Immunol 266 2 116 122 20970781 1:CAS:528:DC%2BC3cXhsFGgs7nE 10.1016/j.cellimm. 2010.09.005
107. MC Heckel A Wolfson CA Slachta R Schwarting P Salgame CD Katsetos CD Platsoucas 2011 Human breast tumor cells express IL-10 and IL-12p40 transcripts and proteins, but do not produce IL-12p70 Cell Immunol 266 2 143 153 21055733 1:CAS:528:DC%2BC3cXhsFGgs7bO 10.1016/j.cellimm.2010.09.010
108. HR Rosen C Ausch M Reinerova E Zaspin K Renner AC Rosen R Schiessel C Moroz 1998 Activated lymphocytes from breast cancer patients express the characteristics of type 2 helper cells-a possible role for breast cancer-associated p43 Cancer Lett 127 1-2 129 134 9619868 1:CAS:528: DyaK1cXitlSksro%3D 10.1016/S0304-3835(98)00017-2 (Pubitemid 28230795)
109. VS Rao A Alabi CE Dyer J Greenman PJ Drew 2008 IL-10 and IL-12 expression in breast cancer patients and effect of therapy-ASCO Annual Meeting Proceedings (Post-Meeting Edition) J Clin Oncol 26 15S 14016
110. Santos SCL, Ribeiro EMSF, Cavalli IJ, Lima RS, da Graça Bicalho M (2005) IL-10 gene polymorphisms and sporadic breast cancer. Hum Immunol 66(8), Supplement 1:53
111. Yu KD, Chen AX, Yang C, Fan L, Huang AJ, Shao ZM (2010) The associations between two polymorphisms in the interleukin-10 gene promoter and breast cancer risk. Breast Cancer Res Treat; doi: 10.1007/s10549-010-1133-3
112. L Giordani P Bruzzi C Lasalandra M Quaranta F Schittulli F Della Ragione A Iolascon 2003 Association of breast cancer and polymorphisms of interleukin-10 and tumor necrosis factor-alpha genes Clin Chem 49 10 1664 1667 14500594 1:CAS:528:DC%2BD3sXnvVyhtL4%3D 10.1373/49.10.1664 (Pubitemid 37194223)
113. KC Smith AC Bateman HM Fussell WM Howell 2004 Cytokine gene polymorphisms and breast cancer susceptibility and prognosis Eur J Immunogenet 31 4 167 173 15265021 1:CAS:528:DC%2BD2cXnsFSjsr8%3D 10.1111/j.1365-2370.2004.00462.x (Pubitemid 39049861)
114. U Langsenlehner P Krippl W Renner B Yazdani-Biuki T Eder H Köppel TC Wascher B Paulweber H Samonigg 2005 Interleukin-10 promoter polymorphism is associated with decreased breast cancer risk Breast Cancer Res Treat 90 2 113 115 15803357 1:CAS:528:DC%2BD2MXivVKhs74%3D 10.1007/s10549-004-3607-7 (Pubitemid 40568894)
115. F Kong J Liu Y Liu B Song H Wang W Liu 2010 Association of interleukin-10 gene polymorphisms with breast cancer in a Chinese population J Exp Clin Cancer Res 29 72 20553628 10.1186/1756-9966-29-72 1:CAS:528:DC%2BC3cXotFOmurw%3D
116. A Gerger W Renner T Langsenlehner G Hofmann G Knechtel J Szkandera H Samonigg P Krippl U Langsenlehner 2010 Association of interleukin-10 gene variation with breast cancer prognosis Breast Cancer Res Treat 119 3 701 705 19437115 1:CAS:528:DC%2BC3cXlslWkuw%3D%3D 10.1007/s10549-009-0417-y
117. DM Turner DM Williams D Sankaran M Lazarus PJ Sinnott IV Hutchinson 1997 An investigation of polymorphism in the interleukin-10 gene promoter Eur J Immunogenet 24 1 1 8 9043871 1:CAS:528:DyaK2sXhsFCjsL0%3D 10.1111/j.1365-2370. 1997.tb00001.x (Pubitemid 27050850)
118. K Kingo R Ratsep S Koks M Karelson H Silm E Vasar 2005 Influence of genetic polymorphisms on interleukin-10 mRNA expression and psoriasis susceptibility J Dermatol Sci 37 2 111 113 15659329 1:CAS:528: DC%2BD2MXkvVektQ%3D%3D 10.1016/j.jdermsci.2004.10.002 (Pubitemid 40126829)
119. E Crawley R Kay J Sillibourne P Patel I Hutchinson P Woo 1999 Polymorphic haplotypes of the interleukin-10 50 flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis Arthritis Rheum 42 6 1101 1108 10366102 1:CAS:528:DyaK1MXktVegt70%3D 10.1002/1529-0131(199906)42:6<1101::AID- ANR6>3.0.CO;2-Y (Pubitemid 29268946)
120. CH Yang LY Chuang YJ Chen HF Tseng HW Chang 2011 Computational analysis of simulated SNP interactions between 26 growth factor-related genes in a breast cancer association study OMICS 15 6 399 407 21599519 1:CAS:528: DC%2BC3MXnsFKkt7Y%3D 10.1089/omi.2010.0028